Roche Holding AG (RHHVF)
Data as of September 4, 2026 · Drug Manufacturers - General
Stockbruh grade: Mixed 3/5 metrics rated Sunny
What does Roche Holding AG do?
Roche Holding AG, the pharmaceutical powerhouse, headquartered in Basel, Switzerland, is on a mission to combat diseases like cancer, diabetes, and Covid-19. With their extensive range of therapies and diagnostic tests, they're fighting to keep our bodies healthy and happy. So, if you're looking for a company that's all about healing and innovation, Roche is your go-to! 💊🌟.
Key Numbers
| Metric | Rating | What it means |
|---|
| Returns (5Y) | ⛅ Moderate | 5-year price performance |
| Profitability | ☀️ Strong | Net margin & return on equity |
| Growth | ⛅ Moderate | Revenue & earnings trend |
| Earnings | ☀️ Strong | EPS vs analyst expectations |
| Cash & Debt | ☀️ Strong | Balance sheet strength |
| Price | $443.25 | Market Cap | — |
| Exchange | Other OTC | | |
Plain-English Analysis
What's it worth?
Performance has been moderate. Sign up free to see Stockbruh's full valuation analysis including price ratios and plain-English commentary.
How the business works
Roche Holding AG, the pharmaceutical powerhouse, headquartered in Basel, Switzerland, is on a mission to combat diseases like cancer, diabetes, and Covid-19. With their extensive range of therapies and diagnostic tests, they're fighting to keep our bodies healthy and happy. Sign up free for competitor and revenue breakdown ↗
Are they building the future?
Growth is mixed — some positive signals, but not consistent. Sign up free for Stockbruh's full growth breakdown.
What's ahead?
Recent earnings have been strong, meeting or beating analyst expectations. Sign up free for earnings history, EPS trends, and what analysts are forecasting next.